Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients With BRAF ‐mutated melanoma and other advanced malignancies

Cancer, EarlyView.

Source: Cancer - November 1, 2018 Category: Cancer & Oncology Authors: Minny Bhatty, Shumei Kato, Sarina A. Piha ‐Paul, Aung Naing, Vivek Subbiah, Helen J. Huang, Daniel D. Karp, Apostolia M. Tsimberidou, Ralph G. Zinner, Wen‐Jen Hwu, Milind Javle, Sapna P. Patel, Mimi I. Hu, Gauri R. Varadhachary, Anthony Source Type: research